XML 55 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense (benefit)
The components of the provision for income taxes are presented in the following table:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Current:
 
 
 
 
 
Federal
$
4,000

 
$

 
$

State
2,000

 

 

Foreign

 
2,170,000

 

 
6,000

 
2,170,000

 

Deferred:
 
 
 
 
 
Federal
(263,000
)
 

 


State

 

 

Foreign

 

 

 
(263,000
)
 

 

 
$
(257,000
)
 
$
2,170,000

 
$

Schedule of effective income tax rate reconciliation
The reconciliation of income taxes attributable to continuing operations computed at the statutory tax rates to income tax expense (benefit), using a 21% statutory tax rate for December 31, 2019 and 2018, and 35% statutory tax rate for December 31, 2017, is as follows: 
 
Year Ended December 31,
 
2019
 
2018
 
2017
Income (benefit) taxes at statutory rates
$
(25,370,000
)
 
$
(19,908,000
)
 
$
(30,872,000
)
State income tax, net of federal benefit

 
(4,000
)
 
(4,000
)
Foreign income taxes

 
2,170,000

 

Change in valuation allowance
25,457,000

 
20,898,000

 
(20,965,000
)
Research and development tax credits
(3,838,000
)
 
(3,170,000
)
 
(3,456,000
)
Change in fair value of warrants

 
(76,000
)
 
(282,000
)
Stock-based compensation
1,114,000

 
1,094,000

 
2,332,000

Uncertain tax positions
1,537,000

 
1,268,000

 
846,000

Expired NOLs and credits
616,000

 
2,176,000

 
454,000

Limited NOLs and credits
(616,000
)
 
(2,176,000
)
 
(165,000
)
Change in tax rates
12,000

 

 
50,019,000

Other
831,000

 
(102,000
)
 
2,093,000

 
$
(257,000
)
 
$
2,170,000

 
$

Schedule of deferred tax assets and liabilities
Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2019 and 2018 are shown below:
 
As of December 31,
 
2019
 
2018
Deferred tax assets:
 
 
 
Capitalized research expense
$
6,300,000

 
$
7,408,000

NOL carryforwards
110,788,000

 
89,399,000

Research and development and other tax credits
11,737,000

 
9,432,000

Deferred revenue
1,506,000

 
985,000

Deferred rent

 
2,013,000

Stock-based compensation
3,255,000

 
3,408,000

Acquired intangibles
889,000

 
912,000

Derivative liability
1,852,000

 

Interest expense
1,122,000

 

Investment in affiliated entity
645,000

 

Lease liability
4,722,000

 

Other
2,413,000

 
2,693,000

 
145,229,000

 
116,250,000

Valuation allowance
(137,159,000
)
 
(115,007,000
)
Total deferred tax assets
8,070,000

 
1,243,000

Deferred tax liabilities:
 
 
 
Acquired intangibles
(160,000
)
 
(142,000
)
Investment in affiliated entity

 
(4,000
)
Right of use asset
(2,894,000
)
 

Note discount
(2,862,000
)
 

Convertible note
(1,381,000
)
 

Fixed assets
(805,000
)
 
(1,121,000
)
Net deferred tax liabilities
$
(32,000
)
 
$
(24,000
)
Schedule of operating loss and tax credit carryforward expirations
Based upon statute, federal and state losses and credits are expected to expire as follows (in millions):
Expiration Date:
Federal NOLs
 
State NOLs
 
Federal R&D
 
State R&D
 
 
 
 
 
 
 
 
2020
$
1.6

 
$

 
$

 
$

2021
2.3

 
0.3

 

 

2022
6.0

 
0.3

 

 

2023
4.5

 
0.4

 

 

2024 and thereafter
282.3

 
148.1

 
17.3

 

Indefinite
186.6

 

 

 
3.2

 
$
483.3

 
$
149.1

 
$
17.3

 
$
3.2

Schedule of unrecognized tax benefits rollforward
The following table summarizes the activity related to the Company's unrecognized tax benefits:
 
Year ended December 31,
 
2019
 
2018
 
2017
Balance at beginning of the year
$
9,632,000

 
$
8,313,000

 
$
6,855,000

Increases related to current year tax positions
1,575,000

 
1,319,000

 
1,532,000

Increases (decreases) related to prior year tax positions
(3,000
)
 

 
(74,000
)
Balance at end of the year
$
11,204,000

 
$
9,632,000

 
$
8,313,000